leyu.ÀÖÓã(¼¯ÍÅ)ÖÇÄܿƼ¼¹É·ÝÓÐÏÞ¹«Ë¾ÍøÕ¾


È«¹ú·þÎñ×ÉѯÈÈÏß:

15000569291

µ±Ç°Î»ÖãºÊ×Ò³  >  ²úÆ·ÖÐÐÄ   >  ÉúÃü¿ÆÑ§  >  

  • ÈËÔ´ÒÒõ£»¯¸ßÃܶÈÖ¬µ°°×»ù±¾ÐÅÏ¢ ²úÆ·±àºÅ£ºPC0298 Ó¢ÎÄÃû£ºHuman Ac-HDL (Human Acetylated High Density Lipoprotein) ÔËÊäÌõ¼þ£º2-8¡æ

    ·ÃÎÊ´ÎÊý£º149
    ²úÆ·¼Û¸ñ£º2800
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • ºìɫӫ¹â±ê¼ÇÈËÔ´¸ßÃܶÈÖ¬µ°°×»ù±¾ÐÅÏ¢ ²úÆ·±àºÅ£ºPC0297 Ó¢ÎÄÃû£ºHuman DiI-HDL (Human DiI-High Density Lipoprotein) ÔËÊäÌõ¼þ£º2-8¡æ

    ·ÃÎÊ´ÎÊý£º125
    ²úÆ·¼Û¸ñ£º2480
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • Ö¬µ°°×ÔÚÈËÌåÖÐÖ÷ÒªÆðµ½ÔËÊäÖ¬ÖÊ£¨ÈçÖ¬ÖÊ¡¢¸ÊÓÍÈýõ¥£©µÄ×÷Ó㬰´ÕÕ·Ö×ÓÁ¿´óС£¬Ö÷Òª·ÖΪÒÔϼ¸ÖÖ£¨´Ó¸ßµ½µÍ£©£ºÈéÃÓ£¨CM£©¡¢¼«µÍÃܶÈÖ¬µ°°× (VLDL)¡¢ÖмäÃܶÈÖ¬µ°°× (IDL)¡¢µÍÃܶÈÖ¬µ°°× (LDL)¡¢¸ßÃܶÈÖ¬µ°°×£¨HDL£©µÈ¡£

    ·ÃÎÊ´ÎÊý£º110
    ²úÆ·¼Û¸ñ£º1500
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • ÖÐÎÄÃû³Æ£ºÑª¹Ü½ôÕÅËØ£¨1-7£© CASºÅ£º51833-78-4 ÖÐÎıðÃû£ºACEÒÖÖÆ¼Á(ANGIOTENSIN1-7);Ѫ¹Ü½ôÕÅËØ(1-7),98%;Ѫ¹Ü½ôÕÅËØ(1-7);»¯ºÏÎïANGIOTENSIN1-7;»¯ºÏÎïLY2584702TOSYLATE;1-7Ѫ¹Ü½ôÕÅËØ(1-7)

    ·ÃÎÊ´ÎÊý£º132
    ²úÆ·¼Û¸ñ£º600
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • ÖÐÎÄÃû³Æ£ºÈËѪ¹Ü½ôÕÅËØIII CASºÅ£º12687-51-3 ÖÐÎıðÃû£ºÈËѪ¹Ü½ôËõËØII´×ËáÑÎË®ºÏÎï;Ѫ¹Ü½ôËõËØIII;[ILE7]-Ѫ¹Ü½ôÕÅËØIIIÒÒËáÑÎË®ºÏÎï;[ILE7]-Ѫ¹Ü½ôÕÅËØIIIÒÒËáÑÎË®ºÏÎï,¡Ý9Chemicalbook5%(HPLC);Ѫ¹Ü½ôÕÅËØIII,¡Ý98.0%(HPCE);»¯ºÏÎïT10322;Ѫ¹Ü½ôËõËØIII/Ѫ¹Ü½ôÕÅËØIII;Ѫ¹Ü½ôÕÅËØIIITFA

    ·ÃÎÊ´ÎÊý£º106
    ²úÆ·¼Û¸ñ£º650
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • ÖÐÎÄÃû³Æ£ºÈËѪ¹Ü½ôÕÅËØII CASºÅ£º4474-91-3 ÖÐÎıðÃû£ºÑª¹Ü½ôÕÅëÄII;Ѫ¹Ü½ôÕÅëÄõ£°·;ÔöÑªÑ¹ËØ,HYPERTENSIN;Ѫ¹Ü½ôÕÅËØ2;Ôö¼ÓÑ¹ËØ;Ѫ¹Ü½ôÕÅËØII|ANGIOChemicalbookTENSINII|ANGIOTENSINII,HUMAN;ANGIOTENSINIIѪ¹Ü½ôÕÅËØ¢ò;Ѫ¹Ü½ôÕÅËØII(ÈË)

    ·ÃÎÊ´ÎÊý£º120
    ²úÆ·¼Û¸ñ£º550
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • MBP£¬Ó¢ÎÄÈ«ÃûMyelin Basic Protein£¬ÖÐÎÄÃûËèÁ×Ö¬¼îÐÔµ°°×£¬Êǹ¹³ÉÖÐÊàÉñ¾­ÏµÍ³£¨CNS£©ËèÁ×Ö¬µÄÖØÒª³É·Ö£¬ÓÉÉÙÍ»½ºÖÊϸ°ûºÍÊ©Íòϸ°û£¨Schwann cells£©ºÏ³É£¬¿ÉÓÃ×÷ÕâÁ½ÖÖϸ°ûµÄ±ê¼ÇÎï¡£MBPÊÇÒ»Ìõµ¥Á´¶àëÄ£¬·Ö×ÓÁ¿Ô¼18.5kDa£¬Î»ÓÚÖÂÃܵÄËèÇʺÍËèºËÖС£ÊÇÒ»ÖÖÓÐDZÁ¦µÄ°ÐÏò¿¹Ô­£¬Äܹ»ÓÕ·¢¶¯Îï²úÉúʵÑéÐÔ¹ýÃôÐÔÄÔ¼¹ËèÑ×£¨EAE£©¡£

    ·ÃÎÊ´ÎÊý£º111
    ²úÆ·¼Û¸ñ£º1150
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
  • ÂÑÇå°×µ°°×¶àëÄ£¨323-339£©»ù±¾ÐÅÏ¢ ²úÆ·±àºÅ£ºPC0286 Ó¢ÎÄÃû£ºOVA Peptide (323-339) ±ðÃû£ºÂÑÇå°×µ°°×¶àëÄ£¨323-339£© CAS No.£º92915-79-2 ÔËÊäÌõ¼þ£º-20¡æ

    ·ÃÎÊ´ÎÊý£º110
    ²úÆ·¼Û¸ñ£º1550
    ³§ÉÌÐÔÖÊ£ºÉú²ú³§¼Ò
    ¸üÐÂÈÕÆÚ£º2026-06-01
¹² 124 Ìõ¼Ç¼£¬µ±Ç° 3 / 16 Ò³  Ê×Ò³  ÉÏÒ»Ò³  ÏÂÒ»Ò³  Ä©Ò³  Ìø×ªµ½µÚÒ³ 

È«¹úͳһ·þÎñµç»°

18721768236£»13122976992

µç×ÓÓÊÏ䣺zhanlingrui@163.com

¹«Ë¾µØÖ·£ºÉϺ£ÊÐãÉÐÐÇø¾°ÁªÂ·439ºÅ5ºÅÂ¥515

ɨÂë¼Ó΢ÐÅ

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿